ArticleAnnales pharmaceutiques francaises2020

[Cov19, seroprevalence studies and Individuals Protection Committees: aren't the technological and organizational challenges enough ?]

C Huriet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.